Ashly E Jordan1,2,3, Charles M Cleland2,4, Katarzyna Wyka1, Bruce R Schackman5, David C Perlman2,6, Denis Nash1. 1. Graduate School of Public Health and Health Policy, City University of New York, New York, New York, USA. 2. Center for Drug Use and HIV Research, New York, New York, USA. 3. Behavioral Science Training Program in Drug Abuse Research, New York University, New York, New York, USA. 4. Division of Biostatistics, Department of Population Health, New York University School of Medicine, New York, New York, USA. 5. Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, New York, USA. 6. Division of Infectious Diseases, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Abstract
BACKGROUND: Hepatitis C virus (HCV) incidence has increased in the worsening opioid epidemic. We examined the HCV preventive efficacy of medication-assisted treatment (MAT), and geographic variation in HCV community viral load (CVL) and its association with HCV incidence. METHODS: HCV incidence was directly measured in an open cohort of patients in a MAT program in New York City between 1 January 2013 and 31 December 2016. Area-level HCV CVL was calculated. Associations of individual-level factors, and of HCV CVL, with HCV incidence were examined in separate analyses. RESULTS: Among 8352 patients, HCV prevalence was 48.7%. Among 2535 patients seronegative at first antibody test, HCV incidence was 2.25/100 person-years of observation (PYO). Incidence was 6.70/100 PYO among those reporting main drug use by injection. Female gender, drug injection, and lower MAT retention were significantly associated with higher incidence rate ratios. Female gender, drug injection, and methadone doses <60 mg were independently associated with shorter time to HCV seroconversion. HCV CVLs varied significantly by geographic area. CONCLUSIONS: HCV incidence was higher among those with lower MAT retention and was lower among those receiving higher methadone doses, suggesting the need to ensure high MAT retention, adequate doses, and increased HCV prevention and treatment engagement. HCV CVLs vary geographically and merit further study as predictors of HCV incidence.
BACKGROUND:Hepatitis C virus (HCV) incidence has increased in the worsening opioid epidemic. We examined the HCV preventive efficacy of medication-assisted treatment (MAT), and geographic variation in HCV community viral load (CVL) and its association with HCV incidence. METHODS:HCV incidence was directly measured in an open cohort of patients in a MAT program in New York City between 1 January 2013 and 31 December 2016. Area-level HCV CVL was calculated. Associations of individual-level factors, and of HCV CVL, with HCV incidence were examined in separate analyses. RESULTS: Among 8352 patients, HCV prevalence was 48.7%. Among 2535 patients seronegative at first antibody test, HCV incidence was 2.25/100 person-years of observation (PYO). Incidence was 6.70/100 PYO among those reporting main drug use by injection. Female gender, drug injection, and lower MAT retention were significantly associated with higher incidence rate ratios. Female gender, drug injection, and methadone doses <60 mg were independently associated with shorter time to HCV seroconversion. HCV CVLs varied significantly by geographic area. CONCLUSIONS:HCV incidence was higher among those with lower MAT retention and was lower among those receiving higher methadone doses, suggesting the need to ensure high MAT retention, adequate doses, and increased HCV prevention and treatment engagement. HCV CVLs vary geographically and merit further study as predictors of HCV incidence.
Keywords:
HCV incidence; epidemics; epidemiology; geographic analysis; hepatitis C virus; injection drug use; opioid use disorder; people who use drugs
Authors: Amanda J Abraham; Christina M Andrews; Colleen M Grogan; Thomas D'Aunno; Keith N Humphreys; Harold A Pollack; Peter D Friedmann Journal: Am J Public Health Date: 2017-01 Impact factor: 9.308
Authors: Ashly E Jordan; Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Denis Nash; David C Perlman Journal: Drug Alcohol Depend Date: 2015-04-13 Impact factor: 4.492
Authors: Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward Journal: MMWR Recomm Rep Date: 2012-08-17
Authors: Aryan Esmaeili; Ali Mirzazadeh; Meghan D Morris; Behzad Hajarizadeh; Henry S Sacks; Lisa Maher; Jason Grebely; Arthur Y Kim; Georg Lauer; Andrea L Cox; Margaret Hellard; Paul Dietze; Julie Bruneau; Naglaa H Shoukry; Gregory J Dore; Andrew R Lloyd; Maria Prins; Kimberly Page Journal: Clin Infect Dis Date: 2018-01-06 Impact factor: 9.079
Authors: Stephanie Popping; Manal El-Sayed; Jordan Feld; Angelos Hatzakis; Margaret Hellard; Olufunmilayo Lesi; Michael Ninburg; John Ward; Charles Boucher Journal: J Virus Erad Date: 2018-07-01
Authors: Lisa R Metsch; Daniel J Feaster; Lauren K Gooden; Carmen Masson; David C Perlman; Mamta K Jain; Tim Matheson; C Mindy Nelson; Petra Jacobs; Susan Tross; Louise Haynes; Gregory M Lucas; Jonathan A Colasanti; Allan Rodriguez; Mari-Lynn Drainoni; Georgina Osorio; Ank E Nijhawan; Jeffrey M Jacobson; Meg Sullivan; David Metzger; Pamela Vergara-Rodriguez; Ronald Lubelchek; Rui Duan; Jacob N Batycki; Abigail G Matthews; Felipe Munoz; Eve Jelstrom; Raul Mandler; Carlos Del Rio Journal: Open Forum Infect Dis Date: 2021-06-27 Impact factor: 4.423
Authors: Samuel R Friedman; Pedro Mateu-Gelabert; Georgios K Nikolopoulos; Magdalena Cerdá; Diana Rossi; Ashly E Jordan; Tarlise Townsend; Maria R Khan; David C Perlman Journal: Glob Public Health Date: 2021-04-11
Authors: Stephanie Popping; Valeria Cento; Carole Seguin-Devaux; Charles A B Boucher; Adolfo de Salazar; Eva Heger; Orna Mor; Murat Sayan; Dominique Salmon-Ceron; Nina Weis; Henrik B Krarup; Robert J de Knegt; Oana Săndulescu; Vladimir Chulanov; David A M C van de Vijver; Federico García; Francesca Ceccherini-Silberstein Journal: Viruses Date: 2021-12-22 Impact factor: 5.048